Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	0.9% normal saline (control)	-	-	-	-	[1] 299 💬
2	0.9% sodium chloride (normal saline)	Chloride ion	[1] D02056 💬	-	-	[1]  6  💬
3	10% metronidazole ointment	Metronidazole	[3] D00409, D05016, D05017 💬	-	-	[1] 96 💬
4	19 nor vitamin d	Vitamin D	-	-	-	[1] 13 💬
5	: immunoglobulina umana normale 10% per somministrazione endovenosa	-	-	-	-	[1] 14 💬
6	[18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane	-	-	-	-	[1]  6  💬
7	[18f]nos	-	-	-	-	[1]  6  💬
8	A novel synthetic, orally-administered, non-peptide small molecule, which acts as	-	-	-	-	[1] 254 💬
9	A-f-a-f (novorapid-fiasp-novorapid-fiasp)	-	-	-	-	[1] 299 💬
10	Administration of a high dose of desipramine	Desipramine	[2] D00812, D07791 💬	[2] SLC6A2, SLC6A4 💬	[2] Serotonergic synapse, Synaptic vesicle cycle	[1] 156 💬
11	Administration of a low dose of desipramine	Desipramine	[2] D00812, D07791 💬	[2] SLC6A2, SLC6A4 💬	[2] Serotonergic synapse, Synaptic vesicle cycle	[1] 156 💬
12	Administration of an ace-inhibitor or not	-	-	-	-	[1] 210 💬
13	Alk-001 (no generic name)	-	-	-	-	[1] 301 💬
14	Amikin, amiklin, amicacin, bb-k8, biklin, fabianol, kaminax, mikavir, novamin, pierami	-	-	-	-	[1] 299 💬
15	Amikin®, amiklin, amicacin, bb-k8, biklin®, fabianol®, kaminax, mikavir, novamin®, pierami	-	-	-	-	[1] 299 💬
16	Amlodipine	Amlodipine	[3] D00615, D02914, D07450 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	[36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[3] 51, 67, 298 💬
17	Amlodipine (drug)	Amlodipine	[3] D00615, D02914, D07450 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	[36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 298 💬
18	Amlodipine gel	Amlodipine	[3] D00615, D02914, D07450 💬	[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	[36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 51 💬
19	Amoxicillin, metronidazole and tetracycline	Amoxicillin	[7] D00201, D00229, D00409, D02925, D05016, D05017, D07452 💬	-	-	[1] 97 💬
20	Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis)	Atazanavir	[3] D00427, D01276, D07471 💬	-	-	[1] 265 💬
21	Atazanavir/ritonavir	Atazanavir	[3] D00427, D01276, D07471 💬	-	-	[1] 265 💬
22	Azithromycin + metronidazole	Azithromycin	[6] D00409, D02134, D05016, D05017, D06390, D07486 💬	-	-	[1] 96 💬
23	Aún no establecido	-	-	-	-	[1] 53 💬
24	Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors	-	-	-	-	[1]  6  💬
25	Bia 9-1067 non-micronized	BIA	-	-	-	[1]  6  💬
26	Bio-enhanced curcumin soft gelatin capsule	Curcumin	[2] D00115, D06892 💬	-	-	[1] 97 💬
27	Biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml)	Human immunoglobulin G	-	-	-	[1] 14 💬
28	Biological: kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml)	Human immunoglobulin G	-	-	-	[1] 14 💬
29	Botox 200u in normal saline	-	-	-	-	[1] 226 💬
30	Candesartan plus non-ccb agents	Candesartan	[1] D00522 💬	[1] AGTR1 💬	[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	[1] 67 💬
31	Cas no.: 7758-16-9	-	-	-	-	[1] 166 💬
32	Catridecacog	Catridecacog	[1] D10532 💬	-	-	[2] 97, 288 💬
33	Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida	-	-	-	-	[1] 274 💬
34	Clarithromycin (not used as of 4/2020)	Clarithromycin	[1] D00276 💬	-	-	[1]  6  💬
35	Coenzyme q-10 in normal control subjects	Ubidecarenone	[1] D01065 💬	-	-	[1] 86 💬
36	Control intervention (no dexamethasone)	Dexamethasone	[9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
37	Corticosteroid and non-biological agents.	-	-	-	-	[1] 46 💬
38	Cysteine	Cysteine	[2] D00026, D02326 💬	-	-	[11]  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
39	Cysteine hydrochloride	Cysteine	[2] D00026, D02326 💬	-	-	[1] 254 💬
40	Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas	-	-	-	-	[1] 274 💬
41	Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada pei nº 12-088)	-	-	-	-	[1] 274 💬
42	Ddavp (desmopressin)	Desmopressin	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[1] 288 💬
43	Desipramine	Desipramine	[2] D00812, D07791 💬	[2] SLC6A2, SLC6A4 💬	[2] Serotonergic synapse, Synaptic vesicle cycle	[4]  6 , 17, 120, 156 💬
44	Desipramine (dmi)	Desipramine	[2] D00812, D07791 💬	[2] SLC6A2, SLC6A4 💬	[2] Serotonergic synapse, Synaptic vesicle cycle	[2]  6 , 17 💬
45	Desmopressin	Desmopressin	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[5]  6 , 64, 72, 225, 288 💬
46	Desmopressin acetat	Desmopressin	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[1]  6  💬
47	Desmopressin acetate	Acetate	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[2] 64, 288 💬
48	Desmopressin acetate trihydrate	Acetate	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[1] 225 💬
49	Desmopressin intranasal	Desmopressin	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[1] 72 💬
50	Desmopressin oral melt	Desmopressin	[2] D00291, D02235 💬	[2] AVPR2, F8 💬	[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	[1] 72 💬
51	Device: no orthosis	-	-	-	-	[1] 70 💬
52	Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation	Oxygen	[1] D00003 💬	-	-	[1] 299 💬
53	Device: non invasive ventilation	-	-	-	-	[1] 299 💬
54	Device: noninvasive ventilation	-	-	-	-	[1] 299 💬
55	Device: novel allergen-specific immune signature directed approach to dietary elimination therapy	-	-	-	-	[1] 98 💬
56	Device: occlusive non adherent dressing	-	-	-	-	[1] 36 💬
57	Device: reciprocating procedure device (rpd) - avanca re no. 1091001	-	-	-	-	[1] 46 💬
58	Dexrazoxane (drz) plus mitoxantrone (mx)	Dexrazoxane	[3] D02166, D03730, D08224 💬	[2] TOP2A, TOP2B 💬	[1] Platinum drug resistance	[1] 13 💬
59	Diagnostic test: nociceptor flexor reflex	-	-	-	-	[1] 149 💬
60	Droxidopa	Droxidopa	[1] D01277 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬	[13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[3]  5 ,  6 , 17 💬
61	Droxidopa 100 mg [northera]	Droxidopa	[1] D01277 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬	[13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
62	Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 222 💬
63	Extavia (interferon beta-1b), novartis pharma ag	Human interferon beta	[1] D00746 💬	[2] IFNAR1, IFNAR2 💬	[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	[1] 13 💬
64	Extended-release quetiapine fumarate	Quetiapine	[2] D00458, D08456 💬	[2] DRD2, HTR2A 💬	[11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway	[1] 13 💬
65	F-a-f-a (fiasp-novorapid-fiasp-novorapid)	-	-	-	-	[1] 299 💬
66	Freeze-dried sulfonated human normal immunoglobulin (ggs)	Human immunoglobulin G	-	-	-	[3] 14, 43, 45 💬
67	From august 2020 'no additional treatment'	-	-	-	-	[1] 51 💬
68	Ga-68-dota-noc	-	-	-	-	[1] 84 💬
69	Gallium68-dota-noc	-	-	-	-	[1] 85 💬
70	Gamma-secretase/notch signalling pathway inhibitor ro4929097	-	-	-	-	[1] 74 💬
71	Gelatin	Gelatin	[2] D00115, D06892 💬	-	-	[4] 28, 78, 97, 269 💬
72	Ginger	Ginger	[1] D06744 💬	-	-	[1] 46 💬
73	Glatiramer acetate 20 mg, with mitoxantrone	Acetate	[3] D02166, D04318, D08224 💬	[22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬	[33] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	[1] 13 💬
74	Glucocorticoids (permitted,not necessary)	-	-	-	-	[1] 46 💬
75	Green tea leaf	Green tea leaf	[1] D06903 💬	-	-	[1] 17 💬
76	Gsk2018682 cd3 non-micronised tablet	-	-	-	-	[1] 13 💬
77	Gsk2018682 cd3 non-micronised tablet in fed state	-	-	-	-	[1] 13 💬
78	Hemin	Hemin	[1] D10003 💬	[2] ALAS1, ALAS2 💬	[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism	[1] 254 💬
79	Hemin for injection	Hemin	[1] D10003 💬	[2] ALAS1, ALAS2 💬	[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism	[1] 254 💬
80	Human normal 10% immunoglobulin for intravenous administration	-	-	-	-	[1] 14 💬
81	Human normal 10% immunoglobulin for intravenous administrationn	-	-	-	-	[1] 14 💬
82	Human normal immunoglobulin	Human immunoglobulin G	-	-	-	[9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
83	Human normal immunoglobulin (iv)	Human immunoglobulin G	-	-	-	[4] 11, 14, 63, 65 💬
84	Human normal immunoglobulin (ivig)	Human immunoglobulin G	-	-	-	[2] 50, 65 💬
85	Human normal immunoglobulin (scig)	Human immunoglobulin G	-	-	-	[1] 14 💬
86	Human normal immunoglobulin (subcutaneous - intramuscular immunoglobulin)	Human immunoglobulin G	-	-	-	[1] 65 💬
87	Human normal immunoglobulin (subcutaneous)	Human immunoglobulin G	-	-	-	[1] 65 💬
88	Human normal immunoglobulin for	Human immunoglobulin G	-	-	-	[1] 65 💬
89	Human normal immunoglobulin for intravenous (iv) administration	Human immunoglobulin G	-	-	-	[1] 51 💬
90	Human normal immunoglobulin for intravenous administration	Human immunoglobulin G	-	-	-	[3] 14, 51, 65 💬
91	Human normal immunoglobulin for intravenous use	Human immunoglobulin G	-	-	-	[2] 63, 65 💬
92	Human normal immunoglobulin for intravenous use (ivig)	Human immunoglobulin G	-	-	-	[1] 65 💬
93	Human normal immunoglobulin for intrvenous use	Human immunoglobulin G	-	-	-	[1] 63 💬
94	Human normal immunoglobulin for subcutaneous administration	Human immunoglobulin G	-	-	-	[2] 51, 65 💬
95	Human normal immunoglobulin for subcutaneous administration (igsc)	Human immunoglobulin G	-	-	-	[1] 65 💬
96	Human normal immunoglobulin g (igg > 98% purity)	Human immunoglobulin G	-	-	-	[3] 14, 63, 65 💬
97	Human normal immunoglobulin g (igg)	Human immunoglobulin G	-	-	-	[1] 11 💬
98	Human normal immunoglogulin (ivig)	Human immunoglobulin G	-	-	-	[1] 50 💬
99	Human recombinant tissue non-specific alkaline phosphatase fusion protein	Alkaline Phosphatase	-	-	-	[1] 172 💬
100	Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy	-	-	-	-	[1]  2  💬
101	Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer	-	-	-	-	[1]  2  💬
102	Immunoglobulina umana normale per somministrazione endovenosa	-	-	-	-	[1] 14 💬
103	Immunoglobulins, normal human	-	-	-	-	[1] 65 💬
104	Immunoglobulins, normal human, for extravascular adm.	-	-	-	-	[1] 14 💬
105	Immunoglobulins, normal human, for intravascular adm.	-	-	-	-	[2] 14, 15 💬
106	Inhaled nitric oxide	Nitric Oxide	[1] D00074 💬	-	-	[2] 85, 86 💬
107	Inhaled nitric oxide & inopulse delivery	Nitric Oxide	[1] D00074 💬	-	-	[1] 86 💬
108	Inhaled nitric oxide - 30 mcg/kg ibw/hr	Nitric Oxide	[1] D00074 💬	-	-	[1] 85 💬
109	Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr	Nitric Oxide	[1] D00074 💬	-	-	[1] 85 💬
110	Inhaled nitric oxide 75 mcg/kg ibw/hr	Nitric Oxide	[1] D00074 💬	-	-	[2] 85, 86 💬
111	Inhaled no with pulsed delivery	-	-	-	-	[1] 86 💬
112	Injection of normal saline	-	-	-	-	[1]  6  💬
113	Inn not available	-	-	-	-	[2] 19, 46 💬
114	Inn not available yet	-	-	-	-	[1] 222 💬
115	Inn not yet proposed	-	-	-	-	[1] 193 💬
116	Intravenous and oral n-acetyl cysteine	Cysteine	[2] D00026, D02326 💬	-	-	[1]  6  💬
117	Istradefylline	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
118	Istradefylline ( kw-6002)	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
119	Istradefylline (kw-6002)	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
120	Istradefylline 20 mg	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
121	Istradefylline 20 mg or 40 mg	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
122	Istradefylline 40 mg	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
123	Kw-6002 (istradefylline)	Istradefylline	[1] D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
124	Leflunomide (permitted, not necessary)	Leflunomide	[1] D00749 💬	[1] DHODH 💬	[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism	[1] 46 💬
125	Lenadogene nolparvovec	-	-	-	-	[1] 302 💬
126	Levobupivacaine	Levobupivacaine	[2] D01287, D08116 💬	[5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	[1] 46 💬
127	Levonorgestrel	Levonorgestrel	[1] D00950 💬	[1] PGR 💬	[4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	[1] 13 💬
128	Loestrin (norethindrone acetate and ethinyl estradiol)	Acetate	[11] D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	[3] ESR1, ESR2, PGR 💬	[11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[1] 299 💬
129	Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)	Acetate	[11] D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	[3] ESR1, ESR2, PGR 💬	[11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[2] 46, 49 💬
130	Lopinavir/ritonavir	Lopinavir	[2] D00427, D01425 💬	-	-	[1] 265 💬
131	Lopinavir/ritonavir + nevirapine	Lopinavir	[3] D00427, D00435, D01425 💬	-	-	[1] 265 💬
132	Lopinavir/ritonavir + zidovudine + lamivudine	Lamivudine	[4] D00353, D00413, D00427, D01425 💬	-	-	[1] 265 💬
133	Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol	Methotrexate	[2] D00142, D02115 💬	[2] DHFR, DHFR2 💬	[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	[1] 46 💬
134	Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.	Methotrexate	[2] D00142, D02115 💬	[2] DHFR, DHFR2 💬	[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	[1] 46 💬
135	Metronidazole	Metronidazole	[3] D00409, D05016, D05017 💬	-	-	[8] 46, 51, 63, 94, 95, 96, 97, 291 💬
136	Metronidazole capsule 50 mg	Metronidazole	[3] D00409, D05016, D05017 💬	-	-	[1] 97 💬
137	Mitoxantrone	Mitoxantrone	[2] D02166, D08224 💬	[2] TOP2A, TOP2B 💬	[1] Platinum drug resistance	[1] 13 💬
138	Monotherapy (lopinavir/ritonavir)	Lopinavir	[2] D00427, D01425 💬	-	-	[1] 265 💬
139	Monotherapy (lopinavir/ritonavir) + abc/3tc	Lopinavir	[2] D00427, D01425 💬	-	-	[1] 265 💬
140	N acetyl cysteine	Cysteine	[2] D00026, D02326 💬	-	-	[2]  6 , 19 💬
141	N-acetyl cysteine	Cysteine	[2] D00026, D02326 💬	-	-	[7] 13, 19, 34, 85, 88, 296, 310 💬
142	N-acetyl cysteine (nac)	Cysteine	[2] D00026, D02326 💬	-	-	[1] 90 💬
143	N-acetyl-cysteine	Cysteine	[2] D00026, D02326 💬	-	-	[1] 84 💬
144	Neoral soft gelatin capsules	Gelatin	[2] D00115, D06892 💬	-	-	[2] 97, 269 💬
145	Nitric oxide	Nitric Oxide	[1] D00074 💬	-	-	[8] 46, 85, 86, 98, 210, 251, 294, 299 💬
146	Nitric oxide 160 ppm	Nitric Oxide	[1] D00074 💬	-	-	[1] 299 💬
147	Nitric oxide for inhalation	Nitric Oxide	[1] D00074 💬	-	-	[2] 86, 299 💬
148	Nitric oxide generated by the geno nitrosyl delivery system	Nitric Oxide	[1] D00074 💬	-	-	[1] 86 💬
149	Nitric oxide plus oxygen	Nitric Oxide	[2] D00003, D00074 💬	-	-	[1] 86 💬
150	Nitric oxide supplement	Nitric Oxide	[1] D00074 💬	-	-	[1] 251 💬
151	No	-	-	-	-	[3] 46, 62, 299 💬
152	Nolpitantium besylate	-	-	-	-	[1] 97 💬
153	Nomegestrol	Nomegestrol	[1] D07222 💬	[1] PGR 💬	[4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	[1] 13 💬
154	Nomegestrol acetate	Acetate	[2] D07222, D08281 💬	[1] PGR 💬	[4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	[1] 13 💬
155	Non applicabile	-	-	-	-	[1] 51 💬
156	Non applicable	-	-	-	-	[2] 10, 19 💬
157	Non as of yet	-	-	-	-	[1] 97 💬
158	Non atg conditioning regimen	-	-	-	-	[1] 60 💬
159	Non propietry, therefore n/a	-	-	-	-	[1] 51 💬
160	Non-anti-tnf biologics	-	-	-	-	[2] 46, 271 💬
161	Non-biologic anti-rheumatic drugs	-	-	-	-	[1] 46 💬
162	Non-biologic disease modifying anti-rheumatic drug (dmard)	-	-	-	-	[1] 46 💬
163	Non-biologic dmards	-	-	-	-	[2] 46, 86 💬
164	Non-biological dmard's	-	-	-	-	[1] 46 💬
165	Non-biological dmards	-	-	-	-	[1] 46 💬
166	Non-myeloablative hematopoietic stem cell transplantation	-	-	-	-	[1] 93 💬
167	Non-nucleoside reverse transcriptase inhibitors	-	-	-	-	[1] 265 💬
168	Non-pegylated interferon	-	-	-	-	[1] 13 💬
169	Non-steroidal anti-inflammatory drug	-	-	-	-	[1] 46 💬
170	Non-steroidal anti-inflammatory drug (nsaid)	-	-	-	-	[1] 46 💬
171	Non-steroidal anti-inflammatory drugs	-	-	-	-	[1] 46 💬
172	Non-steroidal anti-inflammatory drugs (nsaids)	-	-	-	-	[1] 107 💬
173	Nonbiologic dmards of investigator's choice	-	-	-	-	[1] 46 💬
174	None	-	-	-	-	[14] 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬
175	None as of yet	-	-	-	-	[1] 46 💬
176	None assigned	-	-	-	-	[2] 231, 299 💬
177	None at this time	-	-	-	-	[2] 96, 140 💬
178	None given	-	-	-	-	[1] 97 💬
179	Nordiflex	-	-	-	-	[1] 78 💬
180	Nordilet®	-	-	-	-	[1] 78 💬
181	Norditropin	-	-	-	-	[1] 78 💬
182	Norditropin 24 iu	-	-	-	-	[1] 195 💬
183	Norditropin flexpro 10 mg	-	-	-	-	[1] 78 💬
184	Norditropin flexpro 10 mg/1.5 ml	-	-	-	-	[1] 78 💬
185	Norditropin growth hormone	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[1] 78 💬
186	Norditropin nordiflex®	-	-	-	-	[1] 78 💬
187	Norditropin nordiflex® 10 mg/1.5 ml	-	-	-	-	[1] 78 💬
188	Norditropin nordiflex® 10mg/1.5 ml	-	-	-	-	[1] 78 💬
189	Norditropin simplex	-	-	-	-	[1] 78 💬
190	Norditropin simplexx	-	-	-	-	[4]  3 , 78, 193, 195 💬
191	Norditropin simplexx (5mg/1,5 ml) (inn:somatropin)	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[1] 78 💬
192	Norditropin simplexx (growth hormone)	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[1] 78 💬
193	Norditropin simplexx 10 mg	-	-	-	-	[1] 78 💬
194	Norditropin simplexx 15 mg/1.5 ml	-	-	-	-	[1]  3  💬
195	Norditropin simplexx 5mg/1.5ml	-	-	-	-	[1] 78 💬
196	Norditropin®	-	-	-	-	[1] 78 💬
197	Norditropin® flexpro®	-	-	-	-	[1] 78 💬
198	Norditropin® flexpro® pen	-	-	-	-	[1] 78 💬
199	Norditropin® simplexx® 5 mg/1.5ml	-	-	-	-	[1] 78 💬
200	Norepinephrine	Norepinephrine	[2] D00076, D05206 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬	[13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 22 💬
201	Norethindrone	Norethisterone	[2] D00182, D00953 💬	[1] PGR 💬	[4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	[4] 13, 46, 49, 299 💬
202	Norgestimate	Norgestimate	[1] D05209 💬	[1] PGR 💬	[4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	[1] 299 💬
203	Normal human immunoglobulin g	Human immunoglobulin G	-	-	-	[1] 65 💬
204	Normal saline	-	-	-	-	[16]  6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬
205	Normal saline 0.9% infusion solution	-	-	-	-	[1] 22 💬
206	Normal saline enema	-	-	-	-	[1] 97 💬
207	Normal saline for injection	-	-	-	-	[1] 13 💬
208	Normal saline instillation	-	-	-	-	[1] 226 💬
209	Normal saline iv, salt tablets	-	-	-	-	[1] 299 💬
210	Normal saline solution	-	-	-	-	[1] 299 💬
211	Normal saline:	-	-	-	-	[1] 299 💬
212	Normix	-	-	-	-	[1] 96 💬
213	Normix*ad 12cpr riv 200mg	-	-	-	-	[1] 96 💬
214	Norspan	-	-	-	-	[1] 46 💬
215	Northera	-	-	-	-	[1]  6  💬
216	Nortriptyline	Nortriptyline	[2] D00816, D08288 💬	[2] SLC6A2, SLC6A4 💬	[2] Serotonergic synapse, Synaptic vesicle cycle	[2]  6 , 226 💬
217	Nortriptyline hydrochloride	Nortriptyline	[2] D00816, D08288 💬	[2] SLC6A2, SLC6A4 💬	[2] Serotonergic synapse, Synaptic vesicle cycle	[1]  6  💬
218	Norudca	-	-	-	-	[1] 94 💬
219	Norursodeoxycholic acid	norUrsodeoxycholic acid	-	-	-	[1] 94 💬
220	Norvir	-	-	-	-	[2] 265, 299 💬
221	Norvir 100 mg film-coated tablets	-	-	-	-	[1] 299 💬
222	Novamin	-	-	-	-	[1] 299 💬
223	Novantrone	-	-	-	-	[1] 13 💬
224	Novantrone*inf 2mg/ml 5ml	-	-	-	-	[1] 13 💬
225	Novartis pharmaceuticals corporation	-	-	-	-	[1] 13 💬
226	Novatrex	-	-	-	-	[1] 13 💬
227	Novo rapid	-	-	-	-	[1] 299 💬
228	Novo rapid insulin (novonordisk)	-	-	-	-	[1] 299 💬
229	Novolin-r insulin	-	-	-	-	[1] 127 💬
230	Novolog insulin	-	-	-	-	[1] 299 💬
231	Novonorm 0.5 mg	-	-	-	-	[1] 299 💬
232	Novonorm 1 mg	-	-	-	-	[1] 299 💬
233	Novonorm 2 mg	-	-	-	-	[1] 299 💬
234	Novorapid / humalog short acting insulin	-	-	-	-	[1] 299 💬
235	Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen.	-	-	-	-	[1] 299 💬
236	Novorapid aspartate	-	-	-	-	[1] 299 💬
237	Nox-e36	-	-	-	-	[1] 49 💬
238	Noxafil	-	-	-	-	[3] 60, 65, 299 💬
239	Noxafil - 40 mg/ml sospensione orale uso orale flacone (vetro) 105 ml 1 flacone	-	-	-	-	[1] 299 💬
240	Noxafil - oral suspension 40 mg/ml	-	-	-	-	[1] 299 💬
241	Noxafil 100 mg	-	-	-	-	[1] 299 💬
242	Noxafil 40 mg/ml oral solution	-	-	-	-	[1] 65 💬
243	Noxafil gastro resistant tablets	-	-	-	-	[1] 60 💬
244	Noxafil®	-	-	-	-	[2] 60, 299 💬
245	Nsaids (permitted,not necessary)	-	-	-	-	[1] 46 💬
246	Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg	Estradiol	[10] D00105, D00554, D01413, D01617, D01953, D04061, D04063, D04064, D04065, D05209 💬	[3] ESR1, ESR2, PGR 💬	[11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[1] 299 💬
247	Ortho-novum	-	-	-	-	[2] 46, 49 💬
248	Ortho-novum 777	-	-	-	-	[1] 49 💬
249	Ortho-novum® 1/35	-	-	-	-	[1] 46 💬
250	Other non steroidal anti-inflammatory drugs (nsaids) except etodolac	Etodolac	[1] D00315 💬	[1] PTGS2 💬	[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	[1] 46 💬
251	Other non-selective nsaids	-	-	-	-	[1] 271 💬
252	Other non-sponsor pancreatic enzyme replacement therapy	-	-	-	-	[1] 299 💬
253	Other: antigen (wheat base soy sauce) spray	Wheat	[1] D06902 💬	-	-	[1] 98 💬
254	Other: control group(normal saline)	-	-	-	-	[1] 97 💬
255	Other: dietary intervention with no-carrageenan diet	-	-	-	-	[1] 97 💬
256	Other: fractional exhaled no (feno)	-	-	-	-	[1] 96 💬
257	Other: mitoxantrone - immunomodulator	Mitoxantrone	[2] D02166, D08224 💬	[2] TOP2A, TOP2B 💬	[1] Platinum drug resistance	[1] 13 💬
258	Other: no active treatment	-	-	-	-	[1] 274 💬
259	Other: no anti-inflammatory treatment	-	-	-	-	[1] 271 💬
260	Other: no device	-	-	-	-	[1] 13 💬
261	Other: no doxycycline	Doxycycline	[5] D00307, D02129, D03903, D03904, D07876 💬	-	-	[1] 299 💬
262	Other: no enzyme therapy	-	-	-	-	[1] 298 💬
263	Other: no intervention	-	-	-	-	[1] 70 💬
264	Other: no intervention: standard of care	-	-	-	-	[1] 85 💬
265	Other: no it treatment	-	-	-	-	[1] 19 💬
266	Other: no msdmds therapy (control)	-	-	-	-	[1] 13 💬
267	Other: no pancreatic enzyme replacement therapy	-	-	-	-	[1] 299 💬
268	Other: no plasma exchange	-	-	-	-	[2] 43, 44 💬
269	Other: no treatment	-	-	-	-	[2] 53, 256 💬
270	Other: no treatment arm	-	-	-	-	[1] 13 💬
271	Other: no treatment given	-	-	-	-	[1] 78 💬
272	Other: non impact aerobics	-	-	-	-	[1] 13 💬
273	Other: non-hormonal period	-	-	-	-	[1] 299 💬
274	Other: non-motor symptoms	-	-	-	-	[1]  6  💬
275	Other: noninvasive actigraphy monitor	Methamidophos	-	-	-	[1] 86 💬
276	Other: nordic walking (only osteoporosis group)	-	-	-	-	[1]  6  💬
277	Other: normal (control) diet	-	-	-	-	[1] 240 💬
278	Other: normal diet	-	-	-	-	[1] 96 💬
279	Other: normal saline	-	-	-	-	[4] 13, 222, 226, 280 💬
280	Other: normal saline for injection	-	-	-	-	[1] 84 💬
281	Other: oral nitric oxide testing	Nitric Oxide	[1] D00074 💬	-	-	[1] 98 💬
282	Other: sham (no implant)	-	-	-	-	[1] 90 💬
283	Other: sterile normal saline (0.9% nacl)	-	-	-	-	[1] 231 💬
284	Other: wheat flour	Wheat	[1] D06902 💬	-	-	[1] 266 💬
285	Patients' existing non-steroidal anti-inflammatory drug (nsaid) at approved doses	-	-	-	-	[1] 46 💬
286	Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj	Amantadine	[2] D00777, D07441 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬	[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway	[1]  6  💬
287	Posaconazole	Posaconazole	[1] D02555 💬	-	-	[3] 60, 65, 299 💬
288	Posaconazole (psz)	Posaconazole	[1] D02555 💬	-	-	[1] 65 💬
289	Prednison 5, 20 léciva por. tablet nob	-	-	-	-	[1] 50 💬
290	Prednison 5, 20 léciva por. tablet nob.	-	-	-	-	[1] 50 💬
291	Procedure: alcohol wipes vs. no alcohol wipes	Ethanol	[4] D00068, D02798, D04855, D06542 💬	-	-	[1] 13 💬
292	Procedure: audiological and ear, nose and throat examination	-	-	-	-	[1] 78 💬
293	Procedure: exhaled nitric oxide	Nitric Oxide	[1] D00074 💬	-	-	[1] 299 💬
294	Procedure: exhaled nitric oxide assessment	Nitric Oxide	[1] D00074 💬	-	-	[1] 46 💬
295	Procedure: iv deployment of csvf in sterile normal saline iv solution	-	-	-	-	[2] 85, 229 💬
296	Procedure: large bore (19g) histologic needle biopsy of the mediastinal lymph nodes	-	-	-	-	[1] 84 💬
297	Procedure: no celiac block	-	-	-	-	[1] 298 💬
298	Procedure: no gas	-	-	-	-	[2] 86, 88 💬
299	Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit)	-	-	-	-	[1] 49 💬
300	Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation	-	-	-	-	[6] 28, 51, 60, 62, 65, 285 💬
301	Quetiapine	Quetiapine	[2] D00458, D08456 💬	[2] DRD2, HTR2A 💬	[11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway	[2]  6 , 13 💬
302	Rebif new formulation non titrated	-	-	-	-	[1] 13 💬
303	Recombinant human somatotropin	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[2] 78, 236 💬
304	Regular novolin r	-	-	-	-	[1]  6  💬
305	Rhgh norditropin® flexpro® pen (34 µg/kg)	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[1] 78 💬
306	Rifampicin	Rifampicin	[1] D00211 💬	-	-	[5]  6 , 17, 46, 93, 299 💬
307	Rifampin 300mg bid + istradefylline 40mg day 8 only	Istradefylline	[2] D00211, D04641 💬	[1] ADORA2A 💬	[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	[1]  6  💬
308	Ritonavir	Ritonavir	[1] D00427 💬	-	-	[3]  2 , 86, 265 💬
309	Ritonavir (norvir)	Ritonavir	[1] D00427 💬	-	-	[1] 265 💬
310	Rokan (r) novo 120 mg	-	-	-	-	[1] 18 💬
311	Ropivacaine plus normal saline	Ropivacaine	[2] D04048, D08490 💬	[5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	[1] 70 💬
312	Saquinavir and ritonavir	Ritonavir	[3] D00427, D00429, D01160 💬	-	-	[1] 86 💬
313	Sativex oromucosal spray (non-marketed)	-	-	-	-	[1] 13 💬
314	Somatotropin	Somatotropin	[1] D02691 💬	[1] GHR 💬	[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	[3]  3 , 78, 236 💬
315	Sterile normal saline (0.9% nacl)	-	-	-	-	[3] 62, 234, 254 💬
316	Sterile normal saline for intravenous use	-	-	-	-	[2] 85, 229 💬
317	Systemic non-biological treatments	-	-	-	-	[2] 46, 271 💬
318	Tafamidis meglumine 20 mg soft gelatin capsules	Gelatin	[4] D00115, D01796, D06892, D09673 💬	[1] TTR 💬	[1] Thyroid hormone synthesis	[1] 28 💬
319	Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image)	Gelatin	[4] D00115, D01796, D06892, D09673 💬	[1] TTR 💬	[1] Thyroid hormone synthesis	[1] 28 💬
320	Tafamidis meglumine 20mg soft gelatin capsule (commerical image)	Gelatin	[4] D00115, D01796, D06892, D09673 💬	[1] TTR 💬	[1] Thyroid hormone synthesis	[1] 28 💬
321	Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication)	Amoxicillin	[7] D00229, D00276, D00409, D02925, D05016, D05017, D07452 💬	-	-	[1] 63 💬
322	Tamoxifen	Tamoxifen	[2] D00966, D08559 💬	[2] ESR1, ESR2 💬	[9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[4]  2 , 86, 113, 227 💬
323	Tamoxifen 20mg hexal® filmtabletten	Tamoxifen	[2] D00966, D08559 💬	[2] ESR1, ESR2 💬	[9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[1] 113 💬
324	Tamoxifen 40 mg daily for one year	Tamoxifen	[2] D00966, D08559 💬	[2] ESR1, ESR2 💬	[9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[1]  2  💬
325	Tamoxifen citrate	Tamoxifen	[2] D00966, D08559 💬	[2] ESR1, ESR2 💬	[9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	[1] 113 💬
326	The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent.	-	-	-	-	[1] 96 💬
327	There is no recommended inn	-	-	-	-	[1] 65 💬
328	Tnf-a antagonists, non-tnfs, dmard non-biologics	-	-	-	-	[2] 46, 271 💬
329	Topotecan	Topotecan	[2] D02168, D08618 💬	-	-	[1] 25 💬
330	Triamcinolone acetonide and normal saline solution	Triamcinolone	[5] D00385, D00983, D00984, D00985, D06216 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 70 💬
331	Ustekinumab iv - nonresponder - ustekinumab 90mg sc (mp)	Ustekinumab	[1] D09214 💬	[3] IL12A, IL12B, IL23A 💬	[26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	[1] 96 💬
332	Wheat	Wheat	[1] D06902 💬	-	-	[2] 98, 266 💬
333	Zofran - no intubation	-	-	-	-	[1] 98 💬

Back to top